Skip to main content

Day: September 29, 2025

NOVONIX Achieves Critical Operational Milestone

Commercial-grade sampleFirst mass production, industrial-grade sample of synthetic graphite.NOVONIX Riverside FacilityNOVONIX’s Riverside facility in Chattanooga, Tennessee, poised to become the first large-scale production site dedicated to high-performance synthetic graphite for the battery, defense, and industrial sectors in North America.CHATTANOOGA, Tenn., Sept. 29, 2025 (GLOBE NEWSWIRE) — NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX” or the “Company”), a leading battery materials and technology company, announced today the delivery of its first mass production, commercial-grade sample of synthetic graphite for industrial applications to one of North America’s largest value-added carbon processors with a global market reach. “We’re pleased to have hit this significant manufacturing milestone,”...

Continue reading

Enlight Secures Nearly $340 Million in Tax Equity Partnerships for Roadrunner Solar and Energy Storage Project

Roadrunner signs two separate tax equity partnerships: J.P. Morgan for solar, and M&T Bank together with First Citizens Bank, for energy storage Roadrunner, a 290 MW solar and 940 MWh storage project in Arizona, has initiated production of test energy and is expected to reach full COD by the end of 2025 Enlight strengthens its U.S. growth strategy, collaborating with new financing partners to support a robust project pipeline across leading power markets TEL AVIV, Israel, Sept. 29, 2025 (GLOBE NEWSWIRE) — Enlight Renewable Energy (TASE&NASDAQ: ENLT), a leading global renewable energy company, announced today that its U.S. subsidiary Clēnera Holdings has closed two tax equity partnership agreements for the Roadrunner Solar and Energy Storage Project, located near Tucson, Arizona. The first agreement, with J.P. Morgan Chase...

Continue reading

MannKind Appoints Dr. Ajay Ahuja as Executive Vice President and Chief Medical Officer

MannKind CMOMannKind appoints Dr. Ajay Ahuja as EVP, Chief Medical OfficerWESTLAKE VILLAGE, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, today announced the appointment of Ajay Ahuja, MD, MBA, as Chief Medical Officer, effective today. Dr. Ahuja will report directly to Michael Castagna, PharmD, Chief Executive Officer, and will serve on the company’s executive leadership team. “Ajay’s deep expertise in medical affairs, clinical development, and global strategy—combined with his background as a practicing physician—will be instrumental as we continue to advance our pipeline and expand our impact in endocrine and orphan lung...

Continue reading

USA Rare Earth Accelerates Mine-to-Magnet Strategy with the Transformative Acquisition of Less Common Metals (LCM)

Establishes USAR as the Leading Scaled Rare Earth Metal and Alloy Manufacturer Outside of China with Leadership in Samarium, Samarium Cobalt and Neodymium Praseodymium Metals and Alloys Secures Critical Link in USAR’s Supply Chain by Providing Rare Earth Metal and Strip Cast Alloy Capability and Ability to Make Metal from Recycled Rare Earth Oxides Creates Unique Competitive Advantage and Accelerates USAR’s Revenue Generation Ability Significant Revenue Synergies Provided by Access to an Expanded Global Customer Base, Important Supply Chain Relationships and Allied Governments $125 Million Common Stock Equity Investment from Existing Shareholder Provides Capital to Expedite Growth Plans USAR to Host Conference Call at 8:30am ET STILLWATER, Okla., Sept. 29, 2025 (GLOBE NEWSWIRE) — USA Rare Earth, Inc. (Nasdaq: USAR) (USAR or the...

Continue reading

GPTBots Partners with Thai Voice Tech Leader Tellvoice to Revolutionize AI Voice Applications

HONG KONG, Sept. 29, 2025 (GLOBE NEWSWIRE) — GPTBots, a leading enterprise AI agent platform, today announced a strategic partnership with Tellvoice Technology Ltd., Thailand’s premier speech recognition company. This collaboration integrates Tellvoice’s advanced Thai voice recognition capabilities into the GPTBots platform, enabling Thai businesses to build highly accurate, naturally conversational AI voice agents.Combining AI Innovation with Local Expertise This partnership merges GPTBots’ no-code AI development platform with Tellvoice’s decade of expertise in Thai speech recognition. The integration goes beyond basic speech-to-text functionality, leveraging GPTBots’ Retrieval-Augmented Generation (RAG) and Multi-Agent technologies to create AI voice agents that understand context, process complex...

Continue reading

Comment on information published on the Latvian media portal

AS Ekspress Grupp clarifies in connection with the article published today in the Latvian portal nra.lv  that the Group’s Latvian subsidiary AS Delfi indeed had a plan to reduce share capital, but this decision was cancelled on September 19, 2025. This was part of regular group financial structure planning related to the sale of the stake in SIA Altero. The share capital reduction was cancelled and will not take place, as the group decided to use an alternative financial solution. These decisions have no impact on the company’s daily operations or financial position.  The share capital reduction plan has no connection with the business dispute with SIA Ekis & Co-Positioning and Consulting. This company has entered into an agreement with Delfi to manage advertising sales for the news portal LA.lv. Delfi has justified concerns...

Continue reading

GPTBots.ai Partners with Thai Voice Tech Leader Tellvoice to Revolutionize AI Voice Applications

SHENZHEN, China, Sept. 29, 2025 (GLOBE NEWSWIRE) — Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services in China, today announced that its AI agent platform, GPTBots.ai, has established a strategic partnership with Tellvoice Technology Ltd., Thailand’s premier speech recognition company. This collaboration integrates Tellvoice’s advanced Thai voice recognition capabilities into the GPTBots.ai platform, enabling Thai businesses to build highly accurate, naturally conversational AI voice agents. This partnership merges GPTBots.ai’s no-code AI development platform with Tellvoice’s decade of expertise in Thai speech recognition. The integration goes beyond basic speech-to-text functionality,...

Continue reading

RAPT Therapeutics Announces FDA Clearance of IND Application to Proceed to Phase 2b Trial of RPT904 in Food Allergy

RAPT on track to initiate trial this year SOUTH SAN FRANCISCO, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared RAPT’s Investigational New Drug (IND) Application to proceed to a Phase 2b clinical trial of RPT904 for the treatment of patients with food allergy. The planned Phase 2b trial in food allergy is a randomized double-blind placebo-controlled study designed to evaluate the safety and efficacy of RPT904 dosed every 8 weeks (Q8W) and every 12 weeks (Q12W). “Clearance of our IND application, which included data from our Chinese...

Continue reading

Kyivstar Launches Locally Hosted AI Platform In Its Cloud

KYIV, Ukraine, Sept. 29, 2025 (GLOBE NEWSWIRE) — Kyivstar Group Ltd (Nasdaq: KYIV; KYIVW) (“Kyivstar”), a national digital communications operator, today announced it has begun integrating artificial intelligence (AI) technologies into its proprietary cloud platform, Kyivstar Cloud. From now on, Ukrainian businesses and government institutions will have the ability to deploy AI solutions directly within a domestic cloud environment. “Integrating AI into Kyivstar Cloud is not just a technological upgrade — it’s a significant step forward in enhancing Ukraine’s digital resilience,” commented Kostiantyn Vechir, Business Development Director of Kyivstar’s Corporate Market. “AI creates new opportunities for automation, analytics and innovation across industries.”. Key capabilities of the New AI Modules include:real-time big...

Continue reading

Sydbank A/S share buyback programme: transactions in week 39

        Company Announcement No 44/2025Peberlyk 46200 AabenraaDenmark Tel +45 74 37 37 37Fax +45 74 37 35 36 Sydbank A/SCVR No DK 12626509, Aabenraasydbank.dk29 September 2025  Dear Sirs Sydbank A/S share buyback programme: transactions in week 39On 26 February 2025 Sydbank A/S announced a share buyback programme of DKK 1,350m. The share buyback programme commenced on 3 March 2025 and will be completed by 31 January 2026. The purpose of the share buyback programme is to reduce the share capital of Sydbank A/S and the programme is executed in compliance with the provisions of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 and Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, collectively referred to as the Safe Harbour rules. The following transactions have been made...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.